Nature: FDA-approved dopamine agonist for managing elevated prolactin levels, including hyperprolactinemia and prolactinomas.
Mechanism: Targets D2 receptors to inhibit prolactin secretion, leading to tumor shrinkage and normalized prolactin levels.
Usage: Essential for managing side effects of steroids like Trenbolone, NPP, and Deca Durabolin, and as first-line therapy for prolactin-related conditions.
Dosage: 0.25 to 1 milligram per week, orally, in one or two doses, with adjustments based on response and tolerability.
Side Effects: May include nausea, dizziness, headache, and fatigue; rarely, cardiac valve disorders and psychiatric symptoms. Regular monitoring required.